NUFLAM

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

glucosamine sulfate potassium chloride, Quantity: 667 mg (Equivalent: glucosamine sulfate, Qty 500 mg; Equivalent: potassium chloride, Qty 167 mg); shark chondroitin sulfate, Quantity: 278 mg (Equivalent: chondroitin sulfate, Qty 250 mg)

Verfügbar ab:

Zifam Pinnacle Pty Ltd

Darreichungsform:

Capsule, hard

Zusammensetzung:

Excipient Ingredients: Gelatin; calcium hydrogen phosphate dihydrate; sodium lauryl sulfate; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; purified water; titanium dioxide; iron oxide yellow; quinoline yellow

Verabreichungsweg:

Oral

Anwendungsgebiete:

Maintain/support general health and wellbeing ; Decrease/reduce/relieve mild joint aches and pains ; Decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; Helps maintain/supports healthy joint cartilage growth/development/production ; Maintain/support joint health ; Maintain/support joint mobility/flexibility

Produktbesonderheiten:

Visual Identification: ; Container Type: Multiple containers

Berechtigungsstatus:

Listed

Berechtigungsdatum:

2020-12-24